Cite
HARVARD Citation
Badawy, S. et al. (2022). The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study. British journal of haematology. pp. e12-e15. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Badawy, S. et al. (2022). The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study. British journal of haematology. pp. e12-e15. [Online].